JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
IKT - Inhibikase Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary IKT Stock
Financials
Financials IKT Stock
Loading...
Loading...
IKT Stock Price & Analysis - Inhibikase Therapeutics | Ledgeburg
Home
Stocks
Inhibikase Therapeutics, Inc. (IKT)
Stock Overview
Annual
Quarterly
Revenue $USD
0
1M
2M
3M
FY2020
FY2021
FY2022
FY2023
FY2024
Revenue $USD
0
20K
40K
60K
80K
100K
120K
Q2 FY23
Q3 FY23
Q4 FY23
Q1 FY24
Q2 FY24
Q3 FY24
Q4 FY24
Q1 FY25
Q2 FY25
Q3 FY25
Q1 FY26
Company Profile
No description available
Industry
Biotechnology
Sub-Industry
N/A
Employees
N/A
Founded
N/A
Company Website
N/A
Investor Relations
N/A
CEO
N/A
Headquarters
WILMINGTON, DE